SpecGx, LLC FDA Record
- Latest inspection VAI · Feb 27, 2026
- No warning letters matched by name
SpecGx, LLC has 2 FDA recalls, 27 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "SpecGx, LLC" is on file.
- Latest recall
- D-0254-2026 · Class II · Dec 16, 2025
- Latest inspection
- Feb 27, 2026 · VAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 2 | Nov 11, 2026 (checked Nov 15, 2026, unchanged) | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 27 | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
SpecGx, LLC: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 1 | 0 | 0 | 0 | 0 |
| 2025 | 2 | 0 | 0 | 2 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 1 | 0 | 0 | 0 | 0 |
| 2022 | 1 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 2 | 0 | 0 | 0 | 0 |
| 2019 | 4 | 0 | 0 | 0 | 0 |
| 2018 | 2 | 0 | 0 | 0 | 0 |
| 2017 | 0 | 0 | 0 | 0 | 0 |
Reviewing SpecGx, LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check SpecGx, LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0254-2026 | Class II | Oxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster… | Dec 16, 2025 |
| D-0255-2026 | Class II | Oxycodone and Acetaminophen CII Tablets USP, 7.5 mg/325 mg, 100 tablets, Rx only, SpecGx LLC… | Dec 16, 2025 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Feb 27, 2026 | Greenville, IL | Drugs | Voluntary Action Indicated (VAI) | 1419579 |
| Oct 22, 2025 | Saint Louis, MO | Drugs | Voluntary Action Indicated (VAI) | 1940521 |
| Sep 22, 2025 | Raleigh, NC | Drugs | Voluntary Action Indicated (VAI) | 1021320 |
| Sep 18, 2023 | Webster Groves, MO | Drugs | Voluntary Action Indicated (VAI) | 3005275960 |
| Feb 11, 2022 | Saint Louis, MO | Drugs | No Action Indicated (NAI) | 1940521 |
| Mar 16, 2020 | Webster Groves, MO | Drugs | No Action Indicated (NAI) | 3005275960 |
| Mar 13, 2020 | Hobart, NY | Food/Cosmetics | No Action Indicated (NAI) | 1317295 |
| Sep 12, 2019 | Saint Louis, MO | Drugs | Voluntary Action Indicated (VAI) | 1940521 |
| Mar 6, 2019 | Webster Groves, MO | Drugs | No Action Indicated (NAI) | 3005275960 |
| Jan 25, 2019 | Greenville, IL | Drugs | Voluntary Action Indicated (VAI) | 1419579 |
| Jan 25, 2019 | Raleigh, NC | Drugs | No Action Indicated (NAI) | 1021320 |
| Apr 6, 2018 | Hobart, NY | Drugs | No Action Indicated (NAI) | 1317295 |
| Jan 26, 2018 | Webster Groves, MO | Drugs | No Action Indicated (NAI) | 3005275960 |
| Nov 22, 2016 | Saint Louis, MO | Drugs | Voluntary Action Indicated (VAI) | 1940521 |
| Mar 7, 2016 | Greenville, IL | Drugs | Voluntary Action Indicated (VAI) | 1419579 |
| Jan 29, 2016 | Hobart, NY | Drugs | Voluntary Action Indicated (VAI) | 1317295 |
| Aug 26, 2014 | Raleigh, NC | Drugs | No Action Indicated (NAI) | 1021320 |
| Jun 12, 2014 | Saint Louis, MO | Drugs | No Action Indicated (NAI) | 1940521 |
| Aug 30, 2013 | Hobart, NY | Drugs | Voluntary Action Indicated (VAI) | 1317295 |
| May 24, 2013 | Saint Louis, MO | Drugs | No Action Indicated (NAI) | 1940521 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 1419579 | Greenville, IL | 5 | Feb 27, 2026 |
| FEI 1940521 | Saint Louis, MO | 8 | Oct 22, 2025 |
| FEI 1021320 | Raleigh, NC | 4 | Sep 22, 2025 |
| FEI 3005275960 | Webster Groves, MO | 4 | Sep 18, 2023 |
| FEI 1317295 | Hobart, NY | 6 | Mar 13, 2020 |
SpecGx, LLC and the FDA: common questions
Has SpecGx, LLC received an FDA warning letter?
No FDA warning letter addressed to the name "SpecGx, LLC" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has SpecGx, LLC received an FDA Form 483?
FDA has not published a Form 483 for "SpecGx, LLC" in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect SpecGx, LLC?
The most recent FDA inspection on file ended Feb 27, 2026 at Greenville, IL and was classified VAI. FDA has 27 inspections of SpecGx, LLC on file.
Has SpecGx, LLC had an FDA recall?
Yes. SpecGx, LLC has 2 FDA recalls on record. The most recent started Dec 16, 2025.
Need more than this page shows? Ask about SpecGx, LLC in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.